Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

SAR-342434 is as efficacious as insulin lispro in T1DM patients

Sep. 23, 2016

FDA approves Janssen Pharmaceuticals' Invokamet XR

Sep. 22, 2016

Takeda presents phase II results for TAK-448 in men with T2D and HH

Sep. 22, 2016

Long-acting growth hormone CJ-40002 is safe and effective in phase I trial

Sep. 21, 2016

Amgen's phase III GLAGOV study of evolocumab meets endpoints

Sep. 21, 2016

GUB09-145 exerts marked effects on HbA1c, body weight and glucose homestasis in mice

Sep. 20, 2016

PSP/reg shows promise as an assistive biomarker for the diagnosis of DN

Sep. 20, 2016

XOMA updates status of phase II trials of XOMA-358 in severe hypoglycemia

Sep. 20, 2016

SUSTAIN-6 finds reduced cardiovascular outcomes with semaglutide in type 2 diabetes patients

Sep. 20, 2016

Eli Lilly discloses GPR142 agonists

Sep. 20, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...